News

Both guselkumab regimens superior to placebo

By Denise Mann HealthDay ReporterTHURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as “subpotent” active ingredients.The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect …

By Denise Mann HealthDay ReporterTHURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE).CHE is a common condition marked by redness, itching and cracking on the hands and wrists.Anzupgo (delgocitinib cream) is approved …

During same time period, birth rate increased 1 percent, reaching 3,628,934 births

Patients hospitalized with RSV have greater risk for subsequent heart failure events compared with patients with influenza, UTI, fracture

The goal of the federally recognized definition is to provide consistency in research and policy to address health concerns associated with these foods

Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black

After adjustment for multiple confounding variables, chronic kidney disease linked to having fewer than 20 teeth

Tidmarsh's areas of expertise include pediatrics, pediatric oncology, and neonatology

By Beth Gilbert HealthDay ReporterThe annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians, allied health professionals, and others interested in endocrine and metabolic disorders. The conference highlighted recent advances in the diagnosis …